Cargando…
Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research
Colorectal peritoneal metastases (CPM) are associated with abbreviated survival and significantly impaired quality of life. In patients with CPM, radical multimodality treatment consisting of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has demonstrated...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466888/ https://www.ncbi.nlm.nih.gov/pubmed/31065262 http://dx.doi.org/10.1155/2019/5180895 |
_version_ | 1783411194059554816 |
---|---|
author | Koumpa, Foteini Stefania Xylas, Diamantis Konopka, Maciej Galea, Dieter Veselkov, Kirill Antoniou, Anthony Mehta, Akash Mirnezami, Reza |
author_facet | Koumpa, Foteini Stefania Xylas, Diamantis Konopka, Maciej Galea, Dieter Veselkov, Kirill Antoniou, Anthony Mehta, Akash Mirnezami, Reza |
author_sort | Koumpa, Foteini Stefania |
collection | PubMed |
description | Colorectal peritoneal metastases (CPM) are associated with abbreviated survival and significantly impaired quality of life. In patients with CPM, radical multimodality treatment consisting of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has demonstrated oncological superiority over systemic chemotherapy alone. In highly selected patients undergoing CRS + HIPEC, overall survival of over 60% has been reported in some series. These are patients in whom the disease burden is limited and where the diagnosis is made at an early stage in the disease course. Early diagnosis and a deeper understanding of the biological mechanisms that regulate CPM are critical to refining patient selection for radical treatment, personalising therapeutic approaches, enhancing prognostication, and ultimately improving long-term survivorship. In the present study, we outline three broad themes which represent critical future research targets in CPM: (1) enhanced radiological strategies for early detection and staging; (2) identification and validation of translational biomarkers for diagnostic, prognostic, and therapeutic deployment; and (3) development of optimized approaches for surgical cytoreduction as well as more precise strategies for intraperitoneal drug selection and delivery. Herein, we provide a contemporary narrative review of the state of the art in these three areas. A systematic review in accordance with PRISMA guidelines was undertaken on all English language studies published between 2007 and 2017. In vitro and animal model studies were deemed eligible for inclusion in the sections pertaining to biomarkers and therapeutic optimisation, as these areas of research currently remain in the early stages of development. Acquired data were then divided into hierarchical thematic categories (imaging modalities, translational biomarkers (diagnostic/prognostic/therapeutic), and delivery techniques) and subcategories. An interactive sunburst figure is provided for intuitive interrogation of the CPM research landscape. |
format | Online Article Text |
id | pubmed-6466888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-64668882019-05-07 Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research Koumpa, Foteini Stefania Xylas, Diamantis Konopka, Maciej Galea, Dieter Veselkov, Kirill Antoniou, Anthony Mehta, Akash Mirnezami, Reza Gastroenterol Res Pract Review Article Colorectal peritoneal metastases (CPM) are associated with abbreviated survival and significantly impaired quality of life. In patients with CPM, radical multimodality treatment consisting of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has demonstrated oncological superiority over systemic chemotherapy alone. In highly selected patients undergoing CRS + HIPEC, overall survival of over 60% has been reported in some series. These are patients in whom the disease burden is limited and where the diagnosis is made at an early stage in the disease course. Early diagnosis and a deeper understanding of the biological mechanisms that regulate CPM are critical to refining patient selection for radical treatment, personalising therapeutic approaches, enhancing prognostication, and ultimately improving long-term survivorship. In the present study, we outline three broad themes which represent critical future research targets in CPM: (1) enhanced radiological strategies for early detection and staging; (2) identification and validation of translational biomarkers for diagnostic, prognostic, and therapeutic deployment; and (3) development of optimized approaches for surgical cytoreduction as well as more precise strategies for intraperitoneal drug selection and delivery. Herein, we provide a contemporary narrative review of the state of the art in these three areas. A systematic review in accordance with PRISMA guidelines was undertaken on all English language studies published between 2007 and 2017. In vitro and animal model studies were deemed eligible for inclusion in the sections pertaining to biomarkers and therapeutic optimisation, as these areas of research currently remain in the early stages of development. Acquired data were then divided into hierarchical thematic categories (imaging modalities, translational biomarkers (diagnostic/prognostic/therapeutic), and delivery techniques) and subcategories. An interactive sunburst figure is provided for intuitive interrogation of the CPM research landscape. Hindawi 2019-04-01 /pmc/articles/PMC6466888/ /pubmed/31065262 http://dx.doi.org/10.1155/2019/5180895 Text en Copyright © 2019 Foteini Stefania Koumpa et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Koumpa, Foteini Stefania Xylas, Diamantis Konopka, Maciej Galea, Dieter Veselkov, Kirill Antoniou, Anthony Mehta, Akash Mirnezami, Reza Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research |
title | Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research |
title_full | Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research |
title_fullStr | Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research |
title_full_unstemmed | Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research |
title_short | Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research |
title_sort | colorectal peritoneal metastases: a systematic review of current and emerging trends in clinical and translational research |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466888/ https://www.ncbi.nlm.nih.gov/pubmed/31065262 http://dx.doi.org/10.1155/2019/5180895 |
work_keys_str_mv | AT koumpafoteinistefania colorectalperitonealmetastasesasystematicreviewofcurrentandemergingtrendsinclinicalandtranslationalresearch AT xylasdiamantis colorectalperitonealmetastasesasystematicreviewofcurrentandemergingtrendsinclinicalandtranslationalresearch AT konopkamaciej colorectalperitonealmetastasesasystematicreviewofcurrentandemergingtrendsinclinicalandtranslationalresearch AT galeadieter colorectalperitonealmetastasesasystematicreviewofcurrentandemergingtrendsinclinicalandtranslationalresearch AT veselkovkirill colorectalperitonealmetastasesasystematicreviewofcurrentandemergingtrendsinclinicalandtranslationalresearch AT antoniouanthony colorectalperitonealmetastasesasystematicreviewofcurrentandemergingtrendsinclinicalandtranslationalresearch AT mehtaakash colorectalperitonealmetastasesasystematicreviewofcurrentandemergingtrendsinclinicalandtranslationalresearch AT mirnezamireza colorectalperitonealmetastasesasystematicreviewofcurrentandemergingtrendsinclinicalandtranslationalresearch |